MagnetisMM-32
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Experimental Group : Elranatamab
Accepting patients
Active Comparator:Comparator Group: Elotuzumab, Pomalidomide and Dexamethasone
Accepting patients
Comparator Group:Comparator Group: Pomalidomide, Bortezomib and Dexamethasone
Accepting patients
Comparator Group:Comparator Group: Carfilzomib and Dexamethasone
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.